Fundz

Brenus Pharma secures an €11 million Series A extension, led by new European and Asia-Pacific life sciences investors, to enhance its proprietary platform and support clinical-stage developments.

PRIVATEJul 20, 2026

Amount Raised

€11 Million

Round Type

Series A

LyonBiotechnologyHealth CareTherapeutics

Description

Brenus Pharma announced an €11 million ($12.6M) extension to its Series A round, bringing total capital raised since inception to €38 million ($43.5M). This funding reflects strong execution across clinical and regulatory milestones. The company aims to de-risk its lead clinical-stage immunotherapy, STC-1010, while expanding its proprietary platform. New investments come from notable European and Asia-Pacific life sciences investors.

Quick answer

Brenus Pharma raised €11 Million in a Series A round, dated July 20, 2026. Brenus Pharma is based in Lyon, Auvergne Rhône Alpes, France.

How much did Brenus Pharma raise?
Brenus Pharma raised €11 Million in a Series A round on July 20, 2026.
What does Brenus Pharma do?
Brenus Pharma is a biotech company that specializes in the development of precision cancer vaccines.
Where is Brenus Pharma based and how big is it?
Brenus Pharma is based in Lyon, Auvergne Rhône Alpes, France. Fundz records about 28 employees.
Who are the decision-makers at Brenus Pharma?
Fundz holds 2 contacts at Brenus Pharma. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at Brenus Pharma, and when

A new round usually means Brenus Pharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Brenus Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Brenus Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Brenus Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Brenus Pharma

Location

Lyon, Auvergne Rhône Alpes, France

About

Brenus Pharma is a biotech company that specializes in the development of precision cancer vaccines. Their innovative technology platform, STC, utilizes an in-depth understanding of cancer complexity to create new treatment solutions. With a focus on transforming patient care, they aim to enhance immunotherapy outcomes for cancer patients. The company is dedicated to advancing its pipeline, featuring multiple candidates aimed at various solid tumor types.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Brenus Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Brenus Pharma's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Brenus Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.